Medical Dosimetry
Volume 36, Issue 3 , Pages 250-254 , Autumn 2011

A Pelvic Phantom for Modeling Internal Organ Motions

  • Péter Kovács, M.Sc.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary
    • Corresponding Author InformationReprint requests to: Péter Kovács, M.Sc., Institute of Oncotherapy, University of Pécs, Édesanyák útja 17, H-7624, Pécs, Hungary
    • ,
  • Zsolt Sebestyén, M.Sc.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary
    • ,
  • Róbert Farkas, M.D.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary
    • ,
  • Szabolcs Bellyei, M.D., Ph.D.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary
    • ,
  • András Szigeti, M.D., Ph.D.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary
    • ,
  • Gábor Liposits, M.D.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary
    • ,
  • Katalin Hideghéty, M.D., Ph.D.

      Affiliations

    • Oncotherapy Clinic, University of Szeged, Szeged, Hungary
    • ,
  • Katalin Dérczy, M.D.

      Affiliations

    • Department of Radiology, University of Pécs, Pécs, Hungary
    • ,
  • László Mangel, M.D., Ph.D.

      Affiliations

    • Institute of Oncotherapy, University of Pécs, Pécs, Hungary

Received 5 October 2009 ,Accepted 19 April 2010.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA. Cancer. J. Clin. 2009;59:225–249
  2. Boehmer D, Maingon P, Poortmans P, et al. Guidelines for primary radiotherapy of patients with prostate cancer. Radiother. Oncol. 2006;79:259–269
  3. Radiation Therapy Oncology Group. A phase III randomized study of high-dose 3D-CRT/IMRT versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer. RTOG report 0126. 10/18/2004;
  4. Gills S, De Wagter C, Bohsung J, et al. An inter-center quality assurance network for IMRT verification: Results of the ESTRO QUASIMODO project. Radiother. Oncol. 2005;76:340–353
  5. Pinkawa M, Siluschek J, Gagel B, et al. Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer. Radiother. Oncol. 2006;81:284–290
  6. Keros L, Bernier V, Aletti P, et al. Qualitative estimation of pelvic organ interactions and their consequences on prostate motion: Study on a deceased person. Med. Phys. 2006;33:1902–1910
  7. Zelefsky MJ, Crean D, Mageras GS, et al. Quantification and predictors of prostate motion variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother. Oncol. 1999;40:129–133
  8. Hsu A, Pawliczki T, Luxton G, et al. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:898–902
  9. Kupelian PA, Langen KM, Zeidan OA, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006;66:876–882
  10. Orton NP, Tomé WA. The impact of daily shifts on prostate IMRT dose distributions. Med. Phys. 2004;31:2845–2848

PII: S0958-3947(10)00063-4

doi: 10.1016/j.meddos.2010.04.002

Medical Dosimetry
Volume 36, Issue 3 , Pages 250-254 , Autumn 2011

Article Tools

* Image Usage & Resolution